Biocon Biologics has announced a settlement and license agreement with Regeneron, enabling the futur...
read moreAtsena Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Regen...
read moreEyestem Research has announced encouraging results from its Phase 1 clinical trial (NCT06394232) eva...
read moreNextech and Ocuco have entered a strategic partnership aimed at delivering a fully integrated, end-t...
read morePykus Therapeutics has successfully completed patient enrollment in its pilot clinical study, PYK-21...
read moreVantage Biosciences has officially dosed the first patient in its Phase 2 clinical trial evaluating ...
read moreOculis Holding has announced the completion of patient enrollment in both DIAMOND-1 and DIAMOND-2, t...
read moreHarrow has announced the expansion of its Vevye Access for All (VAFA) program, now extending eligibi...
read moreBayer has submitted an application to the European Medicines Agency (EMA) to expand the therapeutic ...
read moreOpus Genetics has reported new 1-month clinical data from the first pediatric patients treated with ...
read more